Project description
Clever device so you don’t miss a dose of insulin
Diabetes affects about 60 million people in Europe and 415 million globally. High blood glucose kills about 3.4 million people annually. The widespread presence of diabetes is increasing among all ages due to obesity, unhealthy diet, and physical inactivity. WHO estimates that diabetes will double between 2005 and 2030. Treatment for type 1 diabetes, and sometimes type 2, involves insulin injections. Forgetting to take insulin injections happens for several reasons and could have severe complications leading to high blood glucose levels or hyperglycaemia. The EU-funded Insulog project presents a handy device that automatically tracks insulin intake. The innovative solution combines a ‘reminder’ of the last insulin doses with an ‘automatic notebook’ to store or download insulin data.
Objective
Many people on insulin report problems of not remembering whether or not they took an injection . Indeed, forgetting to take
insulin can happen to the best of us and is one of the most common reasons for missing an insulin dose. Reasons for
forgetting to take insulin can be diverse, including being stressed, busy and distracted. Missing insulin injections can lead to
a dangerous quandary - do you inject and risk injecting twice, putting yourself at risk of severe hypoglycemia. Or, do you not
inject and risk missing out having injected at all, which could lead to high blood glucose levels (hyperglycemia).
Hyperglycemia could lead to severe complications, including ketoacidsosis and hyperosmolar hyperglycemic nonketotic
syndrome.
Insulog is a handy device that improves the day-to-day life of diabetics by automatically tracking insulin intake. Insulog is the
only solution consisting of a combination of a “reminder” of the last insulin doses and an “automatic notebook” to store or
download insulin data.
The Insulog project has wide European and global dimensions. There are about 60 million people with diabetes in Europe
(9.1% of the European population) and 415 million globally . Prevalence of diabetes is increasing among all ages, mostly
due to increases in obesity, unhealthy diet and physical inactivity. Worldwide, high blood glucose kills about 3.4 million
people annually. Moreover, WHO projects diabetes deaths will double between 2005 and 2030.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences computer and information sciences software
- humanities history and archaeology history
- medical and health sciences clinical medicine endocrinology diabetes
- medical and health sciences health sciences nutrition obesity
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-SMEInst-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
5252236 RAMAT GAN
Israel
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.